A doctor checks a patient's cardiovascular health.

A common medication used to treat high blood pressure could also reduce severity of infection for people suffering with COVID-19, according to new research published Monday in the journal Current Atherosclerosis Reports.
Researches also believe people taking antihypertensives, which could improve survival rates, reduced blood pressure for patients who were taking Angiotensin-Converting Enzyme inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB).
“COVID-19 patients with high blood pressure who were taking ACEi/ARB medications were 0.67 times less likely to have a critical or fatal outcome than those not taking these medications,” lead researcher Dr. Vassilios Vassiliou, said in a statement.
“At the start of the pandemic, there was concern that specific medications for high blood pressure could be linked with worse outcomes for COVID-19 patients,” Vassiliou, a senior clinical lecturer in cardiovascular medicine at the University of East Anglia’s Norwich Medical School, added.
However, Vassiliou warned that his team is NOT recommending that people with high blood pressure and COVID-19 start taking the medications.
“We are not able to address whether starting such tablets acutely in patients with COVID-19 might improve their prognosis, as the mechanism of action might be different,” he said.

Leave a comment

Your email address will not be published. Required fields are marked *